Paid Clinical Trials in Fayetteville, AR
As of August 2026, 60 paid clinical trials are recruiting in Fayetteville, Arkansas. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Fayetteville offers studies at sites including Highlands Oncology Group - Fayetteville for conditions such as Non-Small Cell Lung Cancer, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Fayetteville
Trials by drug in Fayetteville
Filter results
59 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
ALTO-100 in Bipolar Disorder With Depression (BD-D)
Child and Adolescent Registry for Participants With Narcolepsy
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET
Persona Revision Knee System Outcomes
A Multicenter, Postmarket Surveillance Study of Subjects With the Canary canturioTM te Tibial Extension
GAINS Expert Guiding Technology to Coach Life Skill Teaching
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Top Research Study Locations in Fayetteville
Researchers run research studies in Fayetteville, AR at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Highlands Oncology Group - Fayetteville | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8 | 14 |
| University of Arkansas | Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Behavior and Behavior Mechanisms | 8 |
| Highlands Oncology Group | Advanced Non-Small Cell Lung Cancer, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma | 7 |
| Highlands Oncology Group, PA | Glioma, Melanoma, Non-Small Cell Lung Cancer | 7 |
| Center for Human Nutrition | Polycystic Ovary Syndrome (PCOS) | 2 |
| Washington Regional Medical Center | AAA, AAA - Abdominal Aortic Aneurysm, Atrial Fibrillation | 2 |
| Northwest Arkansas Pediatric Clinic | Pneumococcal Disease, Healthy Volunteers, Pneumococcal Immunization | 2 |
| 6039 | Bipolar Disorder I or II With a Major Depressive Episode | 1 |
| Advanced Orthopaedic Specialists | Arthroplasty Complications, Infection, Knee Disease | 1 |
| Clin Trial Inst of Northwest AR | Chronic Spontaneous Urticaria (CSU) | 1 |
| Clinical Trials Institute - Northwest Arkansas | Atopic Dermatitis | 1 |
| Clinical Trials Institute of Northwest Arkansas | Plaque Psoriasis | 1 |
| Don tyson Center for Agricultural Sciencers | Postmenopausal | 1 |
| Highlands Oncology | Metastatic Castration-Resistant Prostate Cancer | 1 |
| National Association of Pasifika Organizations | Cardiometabolic Conditions, Dyslipidemia, Hypertension (HTN) | 1 |
| Northwest Health Physicians' Specialty Hospital | Lumbar Spinal Stenosis | 1 |
| Ozark Orthopaedics | Knee Osteoarthritis | 1 |
| Premier Dermatology Clinical Trials Institute At Northwest Arkansas | NonSegmental Vitiligo | 1 |
| Retina Center of Arkansas | Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration | 1 |
| Surgcenter of Fayetteville | Lumbar Spinal Stenosis | 1 |
| UAMS Fayetteville FMC | Maternal Health | 1 |
| University of Arkansas - Fayetteville | Distress, Emotional | 1 |
| Veterans Health Care System of the Ozarks, Fayetteville, AR | Alcohol Use Disorder (AUD) | 1 |
| Vold Vision P.L.L.C. | Cataract, Glaucoma, Open-Angle | 1 |
Active & Upcoming Studies in Fayetteville (2026)
Recruiting trials in Fayetteville grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (31 active studies)
- Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer · Phase 3 · SWOG Cancer Research Network
- Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations · Phase 3 · SWOG Cancer Research Network
Diabetes & metabolic (2 active studies)
- To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years · University of Hawaii
- Time Restricted Feeding, Muscle, and Metabolism · University of Arkansas, Fayetteville
Cardiovascular (2 active studies)
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation · Biosense Webster, Inc.
- To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years · University of Hawaii
Eye & vision (2 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Results of Patients With Glaucoma Undergoing Minimally Invasive Glaucoma Surgery in Conjunction With Cataract Surgery · Vold Vision P.L.L.C
Mental health & behavior (1 active study)
- ALTO-100 in Bipolar Disorder With Depression (BD-D) · Phase 2 · Alto Neuroscience
Common conditions studied in Fayetteville
- Non-Small Cell Lung Cancer (3 active studies)
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIA Breast Cancer AJCC v8 (2 active studies)
- Anatomic Stage IIIB Breast Cancer AJCC v8 (2 active studies)
- Carcinoma, Non-Small Cell Lung (2 active studies)
- Early Stage Triple-Negative Breast Carcinoma (2 active studies)
Leading research sponsors in Fayetteville
- Pfizer
- National Cancer Institute (NCI)
- University of Arkansas, Fayetteville
- SWOG Cancer Research Network
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Fayetteville?
There are approximately 60 recruiting clinical trials in Fayetteville, Arkansas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Fayetteville pay participants?
Most recruiting trials in Fayetteville compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Fayetteville?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Fayetteville?
The most common conditions under active study in Fayetteville include Non-Small Cell Lung Cancer (3), Anatomic Stage II Breast Cancer AJCC v8 (2), Anatomic Stage IIIA Breast Cancer AJCC v8 (2), Anatomic Stage IIIB Breast Cancer AJCC v8 (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Fayetteville?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Fayetteville on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Fayetteville?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Fayetteville?
Recruiting research sites in Fayetteville include Highlands Oncology Group - Fayetteville, University of Arkansas, Highlands Oncology Group, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Fayetteville right now?
The largest active categories in Fayetteville are Cancer & tumors (31), Diabetes & metabolic (2), Cardiovascular (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.